• Western blot analysis of lysates from 293 cells, using CDKN2A/p16INK4a Rabbit polyclonal antibody (STJ11103827). Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST.

Anti-CDKN2A/p16INK4a antibody (50-156) (STJ11103827)

SKU:
STJ11103827

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CDKN2A/p16INK4a (50-156) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CDKN2A
CDKN2A
Gene ID: 1029
1029
Uniprot ID: CDN2A_HUMAN
ARF_HUMAN
Immunogen Region: 50-156
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 50-156 of human CDKN2A/p16INK4a (NP_000068.1).
Immunogen Sequence: QVMMMGSARVAELLLLHGAE PNCADPATLTRPVHDAAREG FLDTLVVLHRAGARLDVRDA WGRLPVDLAEELGHRDVARY LRAAAGGTRGSNHARIDAAE GPSDIPD
Tissue Specificity
Alternative Antibody Names Anti-Cyclin-Dependent Kinase Inhibitor 2a antibody
Anti-Cyclin-Dependent Kinase 4 Inhibitor A antibody
Anti-Cdk4i antibody
Anti-Multiple Tumor Suppressor 1 antibody
Anti-Mts-1 antibody
Anti-P16-Ink4a antibody
Anti-P16-Ink4 antibody
Anti-P16ink4a antibody
Anti-CDKN2A antibody
Anti-CDKN2 antibody
Anti-MTS1 antibody
Anti-Tumor Suppressor Arf antibody
Anti-Alternative Reading Frame antibody
Anti-Arf antibody
Anti-Cyclin-Dependent Kinase Inhibitor 2a antibody
Anti-P14arf antibody
Anti-CDKN2A antibody
Anti-CDKN2 antibody
Anti-MLM antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance